Alterity Therapeutics在2025年国际帕金森病和运动障碍大会期间发布了其ATH434药物二期临床试验的积极研究数据。
Alterity Therapeutics在2025年国际帕金森病和运动障碍大会期间发布了其ATH434药物二期临床试验的积极研究数据。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.